Department of Ultrasound, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Department of Hepatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Int J Hyperthermia. 2021;38(1):372-381. doi: 10.1080/02656736.2021.1892835.
To compare the long-term outcome of combining hepatectomy with intraoperative ultrasound (IOUS)-guided open microwave ablation (MWA) versus hepatectomy alone in patients with colorectal cancer liver metastases (CRLM).
A retrospective analysis of patients with CRLM who underwent hepatectomy alone (HT group; 380 patients) or hepatectomy combined with IOUS-guided open MWA (HT + MWA group; 57 patients) from April 2002 to September 2018 was conducted at our center. A propensity score-matched (PSM) analysis was used to reduce data bias between the two groups.
The overall survival (OS) and disease-free survival (DFS) were not significantly different between the two groups after matching. Although intrahepatic recurrence was more frequent in the HT + MWA group in both the whole and matched cohort, the two groups exhibited similar rates of extrahepatic recurrence as well as concomitant intra- and extrahepatic recurrence. A higher number of CRLM (>3), larger maximum-size and absence of response to induction chemotherapy were independent risk factors for OS.
The oncological outcomes of hepatectomy combined with intraoperative open ablation was not significantly different to hepatectomy alone and should be considered as a safe and fair option for patients with difficultly resectable CRLM.
比较肝切除术联合术中超声(IOUS)引导下开放微波消融(MWA)与单纯肝切除术治疗结直肠癌肝转移(CRLM)患者的长期疗效。
对 2002 年 4 月至 2018 年 9 月在我院行单纯肝切除术(HT 组;380 例)或肝切除术联合 IOUS 引导下开放 MWA(HT+MWA 组;57 例)的 CRLM 患者进行回顾性分析。采用倾向评分匹配(PSM)分析来减少两组间数据偏倚。
匹配后两组的总生存(OS)和无病生存(DFS)无显著差异。尽管在整个队列和匹配队列中,HT+MWA 组肝内复发更频繁,但两组的肝外复发率以及同时发生的肝内和肝外复发率相似。更多的 CRLM(>3)、最大尺寸更大和对诱导化疗无反应是 OS 的独立危险因素。
肝切除术联合术中开放消融的肿瘤学结果与单纯肝切除术无显著差异,对于难以切除的 CRLM 患者,可考虑作为一种安全且公平的选择。